Trials / Completed
CompletedNCT02596425
Pulmonary Recruitment Maneuver for Postlaparoscopic Shoulder Pain
Pulmonary Recruitment Maneuver to Reduce Postlaparoscopic Shoulder Pain: Randomized Controlled Trial
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- Kangbuk Samsung Hospital · Academic / Other
- Sex
- Female
- Age
- 19 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this clinical trial is to evaluate the efficacy and safety of different recruitment maneuvers for reducing postlaparoscopic shoulder pain.
Detailed description
Shoulder pain after laparoscopy is common and its probable mechanism is residual CO2 gas after surgery. The pulmonary recruitment maneuver can mechanically remove residual CO2 and reduce pain. In literature, there are two different recruitment maneuvers, which was manual inflation of the lungs with positive pressure ventilation of either 40cmH2O or 60cmH2O at the end of surgery. However, the higher positive pressure may be associated with more chance of barotrauma. Therefore, it is important to determine the lowest effective pressure for reducing postlaparoscopic shoulder pain. The aim of this clinical trial is to evaluate the efficacy and safety of different recruitment maneuvers (40cmH2O or 60cmH2O) for reducing postlaparoscopic shoulder pain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | 40 cmH2O | The intervention was five manual inflations of the lungs with positive pressure ventilation of 40 cmH2O at the end of surgery. |
| PROCEDURE | 60 cmH2O | The intervention was five manual inflations of the lungs with positive pressure ventilation of 60 cmH2O at the end of surgery. |
| PROCEDURE | Passive deflation | In the controls, CO2 was removed by the traditional passive deflation of abdominal cavity. |
Timeline
- Start date
- 2015-11-01
- Primary completion
- 2016-05-01
- Completion
- 2016-05-01
- First posted
- 2015-11-04
- Last updated
- 2016-12-01
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02596425. Inclusion in this directory is not an endorsement.